Link between body weight changes and metabolic parameters in drugs naïve subjects with type 2 diabetes treated with canagliflozin monotherapy

Eiji Kutoha Division of Clinical Research, Biomedical Center, Tokyo, Japan;b Division of Endocrinology and Metabolism, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan;c Division of Diabetes and Metabolism, Department of Internal Medicine, Higashitotsuka Memorial Hospital, Yokohama, JapanCorrespondence[email protected]

Asuka Wadab Division of Endocrinology and Metabolism, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan

Alexandra N. Kutoa Division of Clinical Research, Biomedical Center, Tokyo, Japan

Jyunka Hayashib Division of Endocrinology and Metabolism, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan

Rumi Kuriharab Division of Endocrinology and Metabolism, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan

Link between body weight changes and metabolic parameters in drugs naïve subjects with type 2 diabetes treated with canagliflozin monotherapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Link between body weight changes and metabolic parameters in drugs naïve subjects with type 2 diabetes treated with canagliflozin monotherapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date